Last month, we announced the start of our Phase 2B/C clinical trial program, which officially kicked off in Cape Town, South Africa. The South African trial site, part of the clinical research institute TASK, is one of several selected for the project. Hear from our consortium member, Prof. Andreas Diacon, CEO of TASK 👇 @taskapplied @IHIEurope @AMRAccelerator
0
4
12
517
0
Download Video